It has been suggested that the antioxidant-like function of PON1 and Lp-PLA2 may account for the several findings linking altered levels of enzyme activities and the risk of developing T2DM as well as its related clinical complications [12–17]. The gene discussed is PLA2G7; the disease is type 2 diabetes mellitus.